Bullish
Researchers found a brain metastasis weakness — MediciNova plans clinical work
MediciNova (NASDAQ: MNOV) announced a new peer-reviewed study in Cancer Research revealing a vulnerability in brain metastasis involving the MIF–CD74 ...